CRVL

Interested in CorVel Corp.? Here are five stocks we like better. CorVel reported strong fiscal first-quarter results: Revenue rose 11% year over year to $260 million, EPS increased 22% to $0.63, and claims volume grew 8%. New-customer sales increased more than 60% year over year during the quarter. Growth initiatives are expanding across the business: CorVel is deploying AI and automation in claims and clinical workflows, launched Executive Advisory Services and data-driven medical bill repricing, and is advancing CERIS payment-integrity offerings for health plans. The company remains financially flexible: CorVel generated $43.1 million in free cash flow, ended the quarter with $256 million in cash and no debt, and repurchased 377,098 shares for $21.8 million. CorVel (NASDAQ:CRVL) reported June-quarter revenue of $260 million, up 11% from $235 million in the June 2025 quarter, while earnings per share rose 22% to $0.63 from $0.52 a year earlier. Executive Chairman Michael Combs said the results reflected the company’s business strength, employee execution and long-term strategy. The quarter also marked a leadership transition, with Sarah Scott taking over as president and chief executive officer following more than 18 months of succession planning by the board. Combs said he would support Scott and the executive team in his new role as executive chairman. → SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control Chief Financial Officer Brian Nichols said total net income increased 18% year over year in the June 2026 quarter. The company recorded certain one-time items within its CERIS payment-integrity business that increased earnings by approximately $0.07 per share, primarily due to a settlement involving legacy accounts receivable. Nichols added that increases in CorVel’s effective tax rate had a slight negative effect on net income. Even excluding those items, Nichols said underlying business performance remained strong. Patient Management and Network Solutions each contributed approximately $12.5 million of revenue growth during the quarter. Patient Management growth was primarily driven by CorVel’s enterprise claims third-party administrator program. Network Solutions growth was led by the CERIS product. Claims volume increased 8% from the June 2025 quarter, representing the largest annual quarterly increase in claims volume since December 2024. Quarterly year-over-year new-customer sales increased more than 60%, with nearly half of that growth occurring in June. Over the past 12 months, new sales rose 40% compared with the prior 12-month period. → 3 Drone Stocks That Should Soar After the Summer Slump Nichols also said request-for-proposal volume and the average value of opportunities improved significantly from the same quarter a year earlier. Scott said workers’ compensation markets continue to face more complex claims, medical-cost inflation, workforce demographic changes and evolving regulations. She said these conditions support demand for CorVel’s integrated model, which combines claims management, clinical services, pharmacy, bill review, provider networks and ancillary care through its CorVel Connected platform. → The Bitcoin Comeback May Already Be Underway—2 ETFs for Exposure The company is expanding artificial intelligence and automation in selected claims and clinical workflows. Current uses include claims summarization, risk identification and clinical decision support. Scott said the tools are designed to support earlier intervention, consistency and productivity while augmenting professional judgment with transparency, governance and clinical oversight. CorVel has seen encouraging results from individual deployments, Scott said, and is working to standardize measurements of adoption, operational impact and client value as the technology is deployed more broadly. During the quarter, CorVel launched Executive Advisory Services, an offering intended to help clients assess the performance of their workers’ compensation and liability programs. The service combines operational expertise, benchmarking, analytics and technology to identify priorities and develop improvement roadmaps. Scott said the offering could provide standalone value while also helping CorVel identify opportunities to expand existing client relationships. The company also introduced a data-driven medical bill repricing capability to complement its bill-review and Network Solutions businesses. Scott said the offering is designed to support reimbursement decisions, improve processing efficiency and increase consistency in cost-containment results, particularly as out-of-network services and limited state fee schedules contribute to medical costs. In group health, Scott said health plans are managing cost pressure, margin compression and increasing regulatory requirements, factors that reinforce the need for payment-integrity services. CERIS is expanding its capabilities, developing solutions for specialized claim segments and seeking to create additional value with current customers, she said. Scott also pointed to consolidation and alliances among regional health plans, as well as evolving Medicare and Medicaid requirements, as forces reshaping the competitive environment. During the quarter, CERIS invested in its teams and payment-integrity capabilities while advancing several new payer implementations and expanding relationships with existing clients. CorVel sees longer-term potential to apply CERIS’ commercial payment-integrity expertise to selected government healthcare programs, including possible line-item bill-review applications. Scott said the company will evaluate expansion based on demand, program requirements, investment needs and potential returns. CorVel repurchased 377,098 shares during the June quarter for $21.8 million. Since the repurchase program began, the company has bought back 115.6 million shares for a total of $910 million, representing 70% of total shares outstanding at an average price of $7.87 per share, Nichols said. The company funded buybacks through operating cash flow. Days sales outstanding improved to 39 days, one day lower than the prior-year period. CorVel ended the quarter with $256 million in cash and generated free cash flow of $43.1 million, up $3.5 million from the June 2025 quarter, which Nichols attributed to lower net cash used in investing activities. Nichols said CorVel’s liquidity and debt-free position provide flexibility to invest in future growth while maintaining what he described as a continued focus on fiscal responsibility. CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers' compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel's integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support. The company's product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "CorVel Q1 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for August 2026.

FORT WORTH, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended June 30, 2026. Revenues for the quarter were $260 million, an increase from $235 million in the June quarter of 2025. Earnings per share for the quarter were $0.63, compared to $0.52 in the same quarter of the prior year. First Quarter Fiscal Year 2027 Highlights Revenue increased 11% to $260 million, compared to first quarter of fiscal year 2026. Gross profit increased 19% to $67.8 million, at 26% gross margin, compared to first quarter of fiscal year 2026 gross profit of $56.8 million. Diluted earnings per share increased 21% to $0.63, compared to first quarter of fiscal year 2026 diluted earnings per share of $0.52. The Company exited the quarter with $256 million of cash, cash equivalents, and no borrowings. The Company repurchased $21.8 million of common stock during the quarter. During the quarter, CorVel marked the 35th anniversary of its Nasdaq listing by ringing the opening bell with members of its executive leadership team. The milestone reflects the Company's long-standing commitment to disciplined execution, prudent capital management, and sustained investment in innovation, all of which have supported more than three decades of consistent growth and long-term value creation for clients and shareholders In addition, the Company expanded its support for workers’ compensation and liability clients through the introduction of Executive Advisory Services. By combining operational expertise, analytics, benchmarking, and technology, the offering provides clients with actionable insights to reduce costs, improve program performance, and achieve better outcomes while strengthening long-term strategic partnerships. CERIS broadened its payment integrity capabilities through new client implementations and targeted investments designed to improve payment accuracy and help health plans address increasing cost and regulatory pressures. Across both Patient Management and Network Solutions, CorVel remains focused on delivering measurable value by combining deep operational expertise with advanced technology and data-driven insights. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the Company, and events beyond the Company’s control, all of which are subject to change. Such forward-looking statements include, but are not limited to, improved payment accuracy and reducing costs, improving program performance and achieving better outcomes with operational expertise combined with advanced technology. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement. The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2026, and the Company’s Quarterly Report on Form 10-Q for the quarters ended June 30, 2025, September 30, 2025, and December 31, 2025. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason. CorVel CorporationQuarterly Results – Income StatementQuarters Ended June 30, 2026 (unaudited) and June 30, 2025 (unaudited) CorVel CorporationQuarterly Results – Condensed Balance SheetJune 30, 2026 (unaudited) and March 31, 2026

This article first appeared on GuruFocus. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. CorVel Corp (NASDAQ:CRVL) reported a strong 11% revenue increase to $260 million in the June 2026 quarter, with EPS up 22% to $0.63. Claims volume grew by 8% year-over-year, the largest quarterly increase since December 2024, driven by new client implementations and tail claim activity. New customer sales improved by over 60% year-over-year, with a 40% increase in new sales over the last 12 months, indicating strong demand. The company launched Executive Advisory Services and a new data-driven medical bill repricing capability, expanding its service offerings and potential client value. CorVel Corp (NASDAQ:CRVL) maintains a strong financial position with a debt-free balance sheet, $256 million in cash, and improved days sales outstanding of 39 days, supporting continued investment and share repurchases. The quarter included onetime items, such as a settlement of legacy accounts receivable, which increased earnings by approximately $0.07 per share, potentially masking underlying performance. Increases to the effective tax rate had a slight negative impact on net income for the quarter. The workers' compensation market faces ongoing challenges including increasing claim complexity, medical cost inflation, and evolving regulatory environments, which could pressure future results. The group health market is experiencing cost pressure, margin compression, and increasing regulatory requirements, which may affect CERIS's growth prospects. The company's expansion into government health care programs is still in evaluation, with potential returns uncertain and dependent on market demand and investment requirements. Warning! GuruFocus has detected 14 Warning Signs with TRIN. Is CRVL fairly valued? Test your thesis with our free DCF calculator. Q: What were the key financial highlights for the June 2026 quarter, and how did one-time items impact the results?A: Michael Combs (Executive Chairman) reported revenues of $260 million, an 11% increase year-over-year, and EPS of $0.63, up 22% from the prior year. CFO Brian Nichols clarified that a one-time settlement of legacy accounts receivable within Cirrus increased earnings by approximately $0.07 per share, but even excluding this, the underlying business performance remained strong, with total net income up 18%. Q: What were the primary drivers of revenue growth for the quarter?A: Brian Nichols (CFO) stated that both Patient Management and Network Solutions were equal contributors to the revenue increase, each growing by approximately $12.5 million. The CERIS product was the top driver for Network Solutions, while the enterprise claims TPA program drove growth in Patient Management. Q: How did sales performance and claims volume trend during the quarter?A: Brian Nichols (CFO) noted that claims volume grew by 8% year-over-year, the largest increase since December 2024. Quarterly year-over-year new customer sales improved by over 60%, with nearly half of that growth occurring in June. Over the last 12 months, new sales posted a 40% increase compared to the prior period, and RFP volume and average opportunity value also improved significantly. Q: What is the company's strategy regarding artificial intelligence and automation?A: Sarah Scott (President and CEO) explained that CorVel is expanding AI and automation across selected claims and clinical workflows, including claim summarization, risk identification, and clinical decision support. The approach is practical, aiming to augment professional judgment while maintaining transparency, governance, and clinical oversight. The company is standardizing how it measures adoption and operational impact as use expands. Q: What is the new Executive Advisory Services offering, and what is its strategic purpose?A: Sarah Scott (President and CEO) announced the launch of Executive Advisory Services, which helps clients evaluate the performance of their workers' compensation and liability programs. It combines operational expertise, benchmarking, analytics, and technology to help clients identify priorities and develop a road map for improving outcomes. Beyond its stand-alone value, it is designed to deepen client relationships and identify opportunities to expand existing business. Q: How is CorVel addressing medical cost inflation, particularly for out-of-network services?A: Sarah Scott (President and CEO) highlighted the introduction of a new data-driven medical bill repricing capability. This complements existing bill review and network solutions, aiming to support more informed reimbursement decisions, improve processing efficiency, and promote greater consistency in cost containment results. Q: What are the key trends and opportunities in the group health market for CERIS?A: Sarah Scott (President and CEO) noted that health plans face cost pressure and margin compression, reinforcing the need for payment integrity solutions. CERIS is expanding capabilities for specialized claims segments and advancing new payer engagements. The company sees a longer-term opportunity to apply its commercial payment integrity expertise, such as line item bill review, within selected government health care programs, though expansion will be evaluated based on market demand and potential return. Q: What were the details of the company's capital allocation and share repurchase activity?A: Brian Nichols (CFO) reported that CorVel repurchased 377,098 shares at a cost of $21.8 million during the quarter. From inception, the company has repurchased 115.6 million shares for a total of $910 million, representing 70% of total shares outstanding at an average price of $7.87 per share. The company remains debt-free with a cash balance of $256 million at quarter end. Q: How did cash flow and receivables management perform in the quarter?A: Brian Nichols (CFO) stated that free cash flow for the June 2026 quarter was $43.1 million, a $3.5 million increase year-over-year, driven by a reduction in net cash flow used in investing activities. Days sales outstanding improved to 39 days, one day fewer than the same period last year. Q: What is the leadership transition plan, and what is the new CEO's focus?A: Michael Combs (Executive Chairman) confirmed that Sarah Scott's appointment as President and CEO is the culmination of over 18 months of deliberate succession planning. Sarah Scott stated her focus will be on disciplined execution, turning investments into measurable results, and applying what works across the enterprise to create long-term value, building on CorVel's strong foundation and culture. For the complete transcript of the earnings call, please refer to the full earnings call transcript.

FORT WORTH, Texas, July 27, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Wednesday, August 5, 2026, at 11:30 AM Eastern Time. The webcast will feature a discussion of CorVel’s financial performance, strategic initiatives, and outlook, led by Michael Combs, Executive Chairman, Sarah Scott, President and Chief Executive Officer, and Brian Nichols, Chief Financial Officer. The event will also include a dedicated question-and-answer session for attendees. Webcast Details: Date: Wednesday, August 5, 2026 Time: 11:30 AM ET Access: The live webcast can be accessed via Webcast | CorVel Quarterly Earnings Report. A replay of the webcast will be available shortly after the event. Investors, analysts, and interested parties are encouraged to join the webcast to gain insights into CorVel’s performance. Questions may be submitted in advance to [email protected]. About CorVelCorVel Corp. applies technology, including artificial intelligence, machine learning, and natural language processing, to enhance the management of episodes of care and related health care costs. We partner with employers, third-party administrators, insurance companies, and government agencies in managing workers’ compensation and health, auto, and liability services. Our diverse suite of solutions combines our integrated technologies with a human touch. CorVel’s customized services, delivered locally, are backed by a national team to support our partners and their customers and patients. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the Company, and events beyond the Company’s control, all of which are subject to change.   These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement results of operations and financial condition is greater than our initial assessment.  The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025, and the Company’s Quarterly Report on Form 10-Q for the quarters ended June 30, 2025 and September 30, 2025. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.

Earlier this week, CorVel Corporation reported fourth-quarter and full-year 2026 results showing higher sales and earnings, alongside completing a US$20.1 million share repurchase of 346,887 shares between January and March. Beyond headline growth, management emphasized strong momentum in its Network Solutions and CERIS health divisions, underpinned by expanding AI-enabled and automation-focused offerings for payment accuracy and claims management. We’ll now examine how this combination of earnings growth and AI-driven Network Solutions expansion shapes CorVel’s broader investment narrative. Capitalize on the AI infrastructure supercycle with our selection of the 46 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow. For someone considering CorVel, the big picture is about believing in a tech-enabled, niche healthcare services company that is already profitable and trying to deepen its edge in payment accuracy and workers’ comp claims. The latest results, with higher sales and earnings plus a healthy US$233 million cash balance and no debt, reinforce that this is currently an earnings and cash generative story rather than a speculative one. The Q4 report also sharpened the near term catalysts: execution on AI-powered CorVel Connected, continued momentum in Network Solutions and CERIS, and conversion of new contracts into revenue now look more central than macro factors. The recent US$20.1 million buyback and stronger share price over the past quarter support the case that management is confident, but they do not fundamentally change the main risks, which still center on execution, client concentration and valuation after a large multi-year drawdown. However, one operational risk tied to CorVel’s rapid push into AI-enabled solutions may surprise some investors. CorVel's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be. The Simply Wall St Community currently offers 1 fair value estimate clustered at about US$65 per share, highlighting how even a single perspective can differ from market pricing. Set against CorVel’s reliance on successful AI integration and large payer contracts, these community views remind you that performance expectations and risk assessments can vary widely, and it is worth weighing several angles before forming your own view. Explore another fair value estimate on CorVel - why the stock might be worth as much as $65.04! Don't just follow the ticker - dig into the data and build a conviction that's truly your own. A great starting point for your CorVel research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision. Our free CorVel research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CorVel's overall financial health at a glance. Our daily scans reveal stocks with breakout potential. Don't miss this chance: Uncover the next big thing with 25 elite penny stocks that balance risk and reward. The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation. We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CRVL. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

This article first appeared on GuruFocus. Quarterly Revenue: $249 million, a 7% increase from $232 million in the March 2025 quarter. Quarterly Earnings Per Share (EPS): $0.61, up from $0.51 in the same period of the previous year. Fiscal Year Revenue: $959 million, a 7% increase from $896 million in the prior fiscal year. Fiscal Year Earnings Per Share (EPS): $2.14, a 17% increase from $1.83 for the fiscal year ended March 31, 2025. Net Income for Fiscal Year 2026: $110 million, a 14% increase over fiscal year 2025. Fourth Quarter Net Income: $31 million, $5 million higher than the same quarter of fiscal year 2025. Operating Margin for Fiscal Year 2026: 15%, an improvement of 1.4% over 2025. General and Administrative Expenses: Decreased by $1.3 million in the fourth quarter compared to the same quarter of fiscal year 2025. Share Repurchase: 872,744 shares repurchased at a cost of $56 million during fiscal year 2026. Days Sales Outstanding: 37 days in the March 2026 quarter, an improvement of 4 days compared to the previous year. Cash Balance at Fiscal Year-End: $233 million. Free Cash Flow: $66 million, a $7 million increase compared to fiscal year 2025. Warning! GuruFocus has detected 3 Warning Signs with PERI. Is CRVL fairly valued? Test your thesis with our free DCF calculator. Release Date: May 20, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. CorVel Corp (NASDAQ:CRVL) reported a 7% increase in March quarter revenues, reaching $249 million compared to $232 million in the previous year. Earnings per share for the quarter rose to $0.61, up from $0.51 in the same period of the previous year. Network Solutions delivered strong results with double-digit revenue and profit growth, driven by continued momentum across its offerings. New bookings in the March quarter increased 56% year-over-year, indicating high demand and accelerating commercial momentum. CorVel Corp (NASDAQ:CRVL) has a robust and debt-free balance sheet, positioning the company well for strategic product expansion and technological advancement. The effective tax rate increased compared to the prior year, impacting earnings growth. Personnel levels increased to support service delivery, which may affect short-term operational costs. The company is facing rising claims severity and increased medical costs due to an aging workforce and expanded behavioral health considerations. There is ongoing pressure to improve outcomes while controlling costs in the workers' compensation and risk management environment. The increasing sophistication of AI-driven vulnerability discovery is reshaping cybersecurity and operational risk dynamics, requiring further investment in resilience initiatives. Q: Can you provide an overview of CorVel's financial performance for the March quarter and fiscal year 2026? A: Brian Nichols, Chief Financial Officer, reported that the March quarter revenues were $249 million, a 7% increase from $232 million in the March 2025 quarter. Earnings per share for the quarter were $0.61, up from $0.51 in the previous year. For fiscal year 2026, revenues were $959 million, up 7% from $896 million in the prior year, with earnings per share increasing by 17% to $2.14 from $1.83. Q: What were the key drivers of growth in Network Solutions and Patient Management? A: Network Solutions experienced double-digit revenue and profit growth due to strong momentum across its offerings and solid execution in Property & Casualty and Commercial Health. Patient Management saw low single-digit growth, driven by stable demand and a focus on operational efficiency. The company is investing in service quality and technology to support scalable delivery. Q: How is CorVel addressing the evolving healthcare payer environment? A: Michael Combs, President and CEO, explained that CorVel is shifting towards proactive payment accuracy and cost management models. CERIS, a part of CorVel, is expanding its prepay solutions to improve accuracy earlier in the claims life cycle, reducing administrative burdens and strengthening provider partnerships. This shift is supported by new multiyear partnerships with top national payers. Q: What strategic investments is CorVel making to enhance its platform and services? A: CorVel is investing in AI and automation to enhance accuracy, increase throughput, and reduce manual processes. The company is focusing on integrating claims, clinical pharmacy, and network data in real-time to improve decision-making and outcomes. These efforts aim to deliver a technology-enabled, clinically integrated model focused on total claims outcomes. Q: Can you elaborate on CorVel's financial strategy and share repurchase program? A: CorVel's net income for fiscal year 2026 was $110 million, a 14% increase over the previous year. The company repurchased 872,744 shares at a cost of $56 million during the fiscal year, with 366,306 shares repurchased in the fourth quarter. The repurchase program is funded by strong operating cash flow, and CorVel has repurchased 69% of total shares outstanding to date. For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Performance was driven by strong momentum in Network Solutions, particularly within CERIS, which benefited from accelerated post-payment recoveries and large payer engagements. Management is observing a market shift from reactive claim correction to proactive payment accuracy, prompting a strategic focus on expanding prepaid solutions. Patient Management growth reflected stable demand, though results were tempered by targeted investments in personnel and service quality to support new implementations. Rising claim severity and medical complexity in workers' compensation are driving demand for integrated, outcome-focused models over traditional transactional cost management. The 'CorVel Connected' interface is being positioned as a unified operating model that integrates real-time data across claims, clinical, and pharmacy workflows. Operational leverage is being pursued through the deployment of AI-enabled workflow enhancements designed to reduce reliance on manual processes as deployments mature. The company is rearchitecting the claims process around actionable intelligence, using AI to augment clinical professionals rather than replacing them. The launch of four large payer programs, including two top 10 national payers, is expected to contribute meaningfully to revenue and profit in the second half of the calendar year. Management expects personnel levels to normalize as recent implementations mature and automation initiatives are deployed through the remainder of the year and into 2027. The transition toward prepaid solutions is expected to shorten the revenue realization cycle from over six months to approximately one to two months. Ongoing investments in AI and API-driven connectivity are intended to improve throughput and ensure regulatory alignment across the evolving healthcare ecosystem. The company intends to maintain its share repurchase program, funded by strong operating cash flow and a debt-free balance sheet. One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here. One-time events within CERIS, specifically timing-related post-payment recoveries, added $0.02 to earnings per share during the period. The effective tax rate increased year-over-year due to the non-recurrence of a discrete benefit from stock option exercises in the prior year. Management is enhancing governance and resilience initiatives in response to the increasing sophistication of AI-driven cybersecurity vulnerabilities. General and administrative expenses decreased to 9.4% of revenue, down from 10.6% in the prior year's quarter, aiding margin expansion.

Interested in CorVel Corp.? Here are five stocks we like better. CorVel posted solid fiscal 2026 growth, with revenue up 7% to $959 million and EPS up 17% to $2.14. In the March quarter, revenue rose 7% year over year to $249 million and EPS increased to $0.61. Network Solutions and new bookings were major growth drivers, as the segment delivered double-digit revenue and profit gains and quarterly bookings jumped 56% year over year. Management said several large, multi-year payer wins should support revenue and profit growth in the back half of the year and beyond. Profitability improved and CorVel kept returning cash to shareholders, with fiscal 2026 operating margin rising to 15% and free cash flow reaching $66 million. The company also repurchased $56 million of stock during the year and ended with $233 million in cash and no debt. CorVel (NASDAQ:CRVL) said revenue and earnings increased in its March quarter and fiscal 2026, as growth in its Network Solutions business, stronger bookings and operating efficiency helped offset a higher effective tax rate. President and Chief Executive Officer Michael Combs opened the call by saying the company would review its March quarter and fiscal year results, business performance, market trends and progress on product and service offerings. Chief Financial Officer Brian Nichols said March quarter revenue was $249 million, up 7% from $232 million in the March 2025 quarter. Earnings per share for the quarter ended March 31, 2026, were $0.61, compared with $0.51 a year earlier. → Vertical Aerospace: Pre-Flight Checks Point to a Breakout For fiscal 2026, revenue was $959 million, up 7% from $896 million in the prior fiscal year. Earnings per share rose 17% to $2.14 from $1.83 for the fiscal year ended March 31, 2025. Nichols said the company’s effective tax rate increased compared with the prior year, which had included a discrete benefit from stock option exercises that did not recur at similar levels. Nichols said Network Solutions delivered “strong results” in the fiscal year, with double-digit revenue and profit growth. He cited continued momentum across the segment’s offerings and execution in both property and casualty and commercial health. → The Pentagon's AI Pivot Supercharges Defense Stocks Results in Network Solutions included the impact of certain one-time events, primarily within CERiS, which contributed to elevated revenue and profit during the period and added $0.02 to earnings per share. Nichols said the performance was driven by accelerated post-payment recoveries tied to a large payer engagement, which he characterized as a timing-related benefit. He added that the engagement, along with additional large payer wins, is expected to contribute to ongoing revenue and profit tailwinds as the programs scale and mature. → A Deep Dive Into NVIDIA’s Latest Portfolio Moves Patient Management generated low single-digit revenue and profit growth, which Nichols attributed to stable demand and a continued focus on operational efficiency. He said CorVel is making targeted investments to improve service quality and consistency while advancing systems and technology to support more scalable delivery. Personnel levels increased during the period to support service delivery and implementation activity. Nichols said those levels are expected to normalize as deployments mature and as automation and AI-enabled workflow improvements are rolled out through the remainder of the year and into 2027. New bookings in the March quarter increased 56% year over year, according to Nichols, reflecting what he described as high demand and accelerating commercial momentum across the business. Request-for-proposal activity rose 20% over the same period. Nichols said the bookings are primarily multi-year agreements and are expected to contribute meaningfully to revenue and profit growth in the back half of the calendar year as implementations scale. Combs said healthcare payers are operating in a more complex environment, with rising administrative costs, growing claim complexity and pressure to improve financial and clinical outcomes. He said the market is shifting from reactive correction toward proactive models of payment accuracy and cost management. Combs said CERiS is aligned with that shift because its platform spans both prepay and postpaid solutions. He said the approach allows customers to improve accuracy earlier in the claims lifecycle while maintaining recovery capabilities where needed. In 2026, CorVel is launching four large payer programs, including two new multi-year partnerships with top 10 national payers, Combs said. He said those implementations reinforce the company’s value proposition and are expected to contribute meaningfully to revenue and profit growth as they mature. Combs also said prepayment accuracy is becoming a more important strategic priority for payers. He said CERiS is expanding prepaid solutions and migrating services that historically were performed postpaid into more proactive workflows. The move supports revenue streams with a shorter realization cycle, typically one to two months for prepay compared with six months or longer for postpaid, while maintaining comparable margin profiles, he said. Combs said technology remains a key part of CorVel’s strategy, with ongoing investment in artificial intelligence and automation to improve accuracy, increase throughput and reduce reliance on manual processes. He said the company’s approach is focused on augmenting teams by providing actionable insights, improving decision-making and allowing clinical and operational professionals to focus on higher-value work. In workers’ compensation and risk management, Combs said the industry is seeing rising claims severity, higher medical costs and greater complexity tied to an aging workforce, increased comorbidities and expanded behavioral health considerations. He said partners are also facing provider access constraints, regulatory complexity and pressure to improve outcomes while controlling costs. CorVel is advancing its CorVel Connected interface within the CareMC platform, which Combs said brings together AI, real-time data integration and embedded clinical and claims expertise into a unified operating model. He said the platform is intended to support earlier risk identification, faster access to care and more informed decision support throughout the claim continuum. Combs said CorVel is also investing in automation, API-driven connectivity and compliance infrastructure to reduce friction, support regulatory alignment and enable real-time data exchange with partners. He also noted that the company is enhancing its governance framework, strengthening controls and investing in resilience initiatives in response to changing cybersecurity and operational risk dynamics. Nichols said CorVel’s net income for fiscal 2026 was $110 million, nearly a 14% increase from $95 million in fiscal 2025. The fourth quarter contributed $31 million to the fiscal-year total, $5 million higher than the same quarter of fiscal 2025. General and administrative expenses decreased by $1.3 million in the fourth quarter compared with the prior-year quarter, lowering G&A as a percentage of revenue to 9.4% from 10.6%. CorVel’s operating margin for fiscal 2026 was 15%, an improvement of 1.4 percentage points over 2025, Nichols said. During fiscal 2026, CorVel repurchased 872,744 shares at a cost of $56 million, including 366,306 shares in the fourth quarter for $20 million. Since the inception of the repurchase program, the company has repurchased 115.3 million shares for an aggregate total of $868 million, representing 69% of total shares outstanding at an average price of $7.70 per share. CorVel ended the fiscal year with $233 million in cash. Free cash flow was $66 million, up $7 million from fiscal 2025. Nichols said the company’s “robust and debt-free balance sheet” positions it for strategic product expansion, technological advancement and acquisition opportunities. The call concluded without questions from participants. CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers' compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel's integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support. The company's product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "CorVel Q4 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for May 2026.